Showing results (151-160 of 2,346) with videos related to

Sort By:
Pageof 235
Addiction Biology|November 22, 2019
25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potentialRaly James Perez Custodio, Leandro Val Sayson, Chrislean Jun Botanas, et al.
Addiction Biology|November 13, 2019
Cue-induced effects on decision-making distinguish subjects with gambling disorder from healthy controlsAlexander Genauck, Milan Andrejevic, Katharina Brehm, et al.
Addiction Biology|November 28, 2017
Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in womenMaría Antón, Alicia Rodríguez-González, Inmaculada Concepción Rodríguez-Rojo, et al.
Addiction Biology|December 15, 2017
Quantitative evaluation of cue-induced reinstatement model for evidence-based experimental optimizationJulia Oberhofer, Hamid R Noori
Addiction Biology|December 2, 2017
Neuropeptide CART prevents memory loss attributed to withdrawal of nicotine following chronic treatment in miceChandrashekhar D Borkar, Sneha Sagarkar, Amul J Sakharkar, et al.
Addiction Biology|January 24, 2019
Reconsolidation impairment of reward memory by stimulating stress responseChristina Dinter, Derik Hermann, Judith Heckmann, et al.
Addiction Biology|December 21, 2019
The gray matter structural connectome and its relationship to alcohol relapse: Reconnecting for recoverySusanne G Mueller, Dieter J Meyerhoff
Addiction Biology|December 23, 2019
Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic usersNatasha L Mason, Eef L Theunissen, Nadia R P W Hutten, et al.
Addiction Biology|March 9, 2018
Drinking despite adversity: behavioral evidence for a head down and push strategy of conflict-resistant alcohol drinking in ratsDavid Darevsky, Thomas Michael Gill, Katherine Rose Vitale, et al.
Addiction Biology|March 3, 2018
Preclinical evidence for combining the 5-HT2C receptor agonist lorcaserin and varenicline as a treatment for nicotine dependencePaul J Fletcher, Zhaoxia Li, Leo B Silenieks, et al.
Pageof 235